Edesa Biotech, Inc. — Director's Dealing 2020

Feb 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2020-02-12

Reporting Person: MacDonald Sean Arthur (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Share Option (Right to Buy)	$3.16	A	11389	Acquired	2030-02-12	Common Shares (11389)	Direct

Footnotes

F1: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested.